Key statistics
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 139.02 |
---|---|
High | 143.58 |
Low | 137.93 |
Bid | 141.05 |
Offer | 142.31 |
Previous close | 139.33 |
Average volume | 795.97k |
---|---|
Shares outstanding | 55.14m |
Free float | 53.38m |
P/E (TTM) | -- |
Market cap | 7.82bn USD |
EPS (TTM) | -2.96 USD |
Data delayed at least 15 minutes, as of Nov 09 2024.
More ▼
- Glaukos Announces Participation in Upcoming Investor Conferences
- Glaukos Announces Third Quarter 2024 Financial Results
- Glaukos Announces Positive Topline Outcomes in Phase 3 Confirmatory Trial for Epioxa™, Achieving Primary Efficacy Endpoint and Demonstrating Favorable Tolerability and Safety
- Glaukos To Present Multiple Scientific Abstracts at the 2024 American Academy of Ophthalmology Annual Meeting
- Glaukos to Release Third Quarter 2024 Financial Results after Market Close on November 4
More ▼